Anti-LRC3B/ LRRC3B/ LRP15 functional antibody

Anti-LRC3B/ LRRC3B/ LRP15 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LRRC3B/LRRC3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0319-Ab-1/ GM-Tg-hg-SE0319-Ab-2Anti-Human LRRC3B monoclonal antibodyHuman
GM-Tg-rg-SE0319-Ab-1/ GM-Tg-rg-SE0319-Ab-2Anti-Rat LRRC3B monoclonal antibodyRat
GM-Tg-mg-SE0319-Ab-1/ GM-Tg-mg-SE0319-Ab-2Anti-Mouse LRRC3B monoclonal antibodyMouse
GM-Tg-cynog-SE0319-Ab-1/ GM-Tg-cynog-SE0319-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRC3B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0319-Ab-1/ GM-Tg-felg-SE0319-Ab-2Anti-Feline LRRC3B monoclonal antibodyFeline
GM-Tg-cang-SE0319-Ab-1/ GM-Tg-cang-SE0319-Ab-2Anti-Canine LRRC3B monoclonal antibodyCanine
GM-Tg-bovg-SE0319-Ab-1/ GM-Tg-bovg-SE0319-Ab-2Anti-Bovine LRRC3B monoclonal antibodyBovine
GM-Tg-equg-SE0319-Ab-1/ GM-Tg-equg-SE0319-Ab-2Anti-Equine LRRC3B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0319-Ab-1/ GM-Tg-hg-SE0319-Ab-2; GM-Tg-rg-SE0319-Ab-1/ GM-Tg-rg-SE0319-Ab-2;
GM-Tg-mg-SE0319-Ab-1/ GM-Tg-mg-SE0319-Ab-2; GM-Tg-cynog-SE0319-Ab-1/ GM-Tg-cynog-SE0319-Ab-2;
GM-Tg-felg-SE0319-Ab-1/ GM-Tg-felg-SE0319-Ab-2; GM-Tg-cang-SE0319-Ab-1/ GM-Tg-cang-SE0319-Ab-2;
GM-Tg-bovg-SE0319-Ab-1/ GM-Tg-bovg-SE0319-Ab-2; GM-Tg-equg-SE0319-Ab-1/ GM-Tg-equg-SE0319-Ab-2
Products NameAnti-LRRC3B monoclonal antibody
Formatmab
Target NameLRRC3B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRRC3B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0319-Ag-1Recombinant multi-species LRC3B/ LRRC3B/ LRP15 protein


    Target information

    Target IDGM-SE0319
    Target NameLRRC3B
    Gene ID116135,218763,305705,701323,485639,101086594,783571,100051404
    Gene Symbol and SynonymsLRP15,LRRC3B,RGD1311897
    Uniprot AccessionQ96PB8,A6H789
    Uniprot Entry NameLRC3B_HUMAN,LRC3B_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000179796
    Target ClassificationTumor-associated antigen (TAA)

    The target: LRRC3B, gene name: LRRC3B, also named as LRP15. The protein encoded by this gene is a tumor suppressor, with lowered expression levels found in gastric, renal, colorectal, lung, and breast cancer tissues. The promoter of this gene is frequently hypermethylated in these cancer tissues, although the hypermethylation does not appear to be the cause of the reduced expression of this gene. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.